FUJIFILM Diosynth Biotechnologies to acquire new site

On March 12, FUJIFILM Diosynth Biotechnologies (FDB), announced that it will acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark. FDB is a renowned Contract Development and Manufacturing Organization (CDMO) with bases in the UK and USA, this will be the company’s fourth biopharmaceutical contract development and manufacturing site.

The purchase will costs approximately $890 million and is expected to be completed by August 2019. FDB will retain the existing workforce of approximately 800 at the site.

“We are so excited to welcome the Biogen Hillerød team into the FUJIFILM Diosynth Biotechnologies family. These world-class facilities are rivalled only by the experience and capabilities of the Biogen Hillerød team with approximately 800 employees, and we look forward to leveraging these skills for the benefit of current and future customers.”

Steve Bagshaw, CEO, FUJIFILM Diosynth Biotechnologies


Read more from Fujifilm and Biogen

Leave a Reply

Your email address will not be published. Required fields are marked *